# Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States.

> PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32863841-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-11-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32863841-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-32863841-linaclotide-v1.json
- Content SHA-256: `0d73b58a3094aab6f5344eb024448444f4b4dfe05041b30b011e0d465e074070`

## Claims and source pins

### Headline

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

### Summary

PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

### Paragraph 1

PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

## Sources

<a id="source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38"></a>
- **Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States. · retained source version 1:2023-11-12:current:8489278e6d3874ece29b81e528b94fd4343163aa492f68683f6bf58c6d27e0de** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32863841/) (`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-32863841-linaclotide-v1.json SHA-256: 0d73b58a3094aab6f5344eb024448444f4b4dfe05041b30b011e0d465e074070.